Premenstrual Syndrome
Conditions
Interventions
None listed
Sponsors
IMEQRD Co., Ltd.
Human Metabolome Technologies, Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Females aged 18-39 years at the time of informed consent 2)Subjects with BMI 18.5 to 25 kg/m2 3)Subjects who have a stable menstrual cycle within the normal range (25 to 38 days) 4)Subjects who can input electronic diaries using PCs, smartphones, etc 5)Subjects who have received a sufficient explanation of the purpose and contents of the examination, can consent, have well understood, volunteered to participate, and have signed the informed consent document
Exclusion criteria
Exclusion criteria: 1)Subjects who are currently pregnant or breastfeeding, and subjects who wish to become pregnant during the study period 2)Subjects taking hormonal contraceptives (including low-dose pills) 3)smoker 4)Subjects with a history of and presenting psychiatric illness 5)Subjects with surgical injuries or medical conditions that may affect study conduct 6)Subjects with iron deficiency anemia (hemoglobin <11.5g / dl) 7)Subjects who plan to change their lifestyle (eating, sleeping, exercise habits, etc.) significantly during the test period, such as long-term travel 8)Subjects who have collected more than 200 ml of blood within 12 weeks before the start of the study 9)Subjects who are judged to be inappropriate by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Associations between PMS and blood compositions | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Associations between PMS and lifestyle habits 2)Associations between PMS and background information 3)Associations between PMS and intakes | — |
Countries
Japan
Contacts
Public ContactYusuke Aachi
AJINOMOTO CO., INC. Institute of Food Sciences and Technologies
Outcome results
None listed